Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Intrum issues a five year and three months, EUR 75 million private placement bond

Intrum has issued a five year and three months, EUR 75 million senior unsecured fixed rate note (the “Notes”). Application will be made to list the Notes on the Securities Official List of the Luxembourg Stock Exchange. The offering of the Notes is expected to close on December 13, 2019, subject to customary closing conditions. The proceeds will be used to repay certain drawings under Intrum’s revolving credit facility and for general corporate purposes.  For further information, please contact:Emil Folkesson, Group Treasury Director+46 8 546 102 02 emil.folkesson@intrum.com

Archer Limited: Archer awarded a 4 year contract extension from Equinor for the Peregrino Field offshore

Hamilton, Bermuda (December 9, 2019) Archer Limited announces that effective from the 1st December 2020, Equinor Brasil Oleo e Gas Ltda. have confirmed a new 4 year contract for the provision of Platform Drilling Management Services on their Peregrino Field Development on the Peregrino A and B platforms respectively. The new four year contract awarded will be in direct continuation of Archer’s current contract, and will further extend Archer’s continuous relationship with Equinor in Brazil to over 15 years since Peregrino A drilling start-up of operations in 2009. The contract award

DreamHack announces 2020 World Tour schedule – festival to visit 10 cities in Europe, North America, and Asia

DreamHack Returns to Leipzig, Dallas, Jönköping, Valencia, Montreal, Rotterdam, India, Atlanta, and Sevilla DreamHack to Make U.S. West Coast Debut in Anaheim, CaliforniaSTOCKHOLM — Today, Monday, December 9, 2019, DreamHack  marks its 25th anniversary with “DreamHack Day” — a celebration of the festival’s early beginnings in 1994. What started as a gathering of friends and their computers in a school cafeteria — with no online access — has grown into a beacon of internet culture and a gathering place for gamers worldwide featuring everything gaming under one roof.

Additional update regarding Fastpartner’s offer of D-shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA, NEW ZEELAND, JAPAN, SWITZERLAND, OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. ADDITIONAL RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENT.On 5 December 2019, Fastpartner AB (publ) announced that Swedbank AB (publ) had received orders exceeding the base offer of up to 7,000,000 common shares of series D (“D-

Optomed Plc - Managers' Transactions

Optomed Plc - Managers' Transactions - 9 December 2019 at 16.30 EET Optomed Plc - Managers' Transactions ____________________________________________ Person subject to the notification requirementName: Mankato Capital LimitedPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Torstensson, AndersPosition: Member of the Board Issuer: Optomed PlcLEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATIONReference number: 7437009IVYWGEE4S7B77_20191209102426_3_________________________________

Optomed Oyj - Managers' Transactions

Optomed Plc - Managers' Transactions - 9 December 2019, at 16.30 EET Optomed Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Salonen PetriPosition: Member of the Board/Deputy memberIssuer: Optomed OyjLEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATIONReference number: 7437009IVYWGEE4S7B77_20191209094644_5____________________________________________ Transaction date: 2019-12-05Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000410881Nature of the

Optomed Oyj - Managers' Transactions

Optomed Plc - Managers' Transactions - 9 December 2019, at 16.30 EET Optomed Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Salonen NataliaPosition: Closely associated person (1):Person Discharging Managerial Responsibilities In IssuerName: Salonen PetriPosition: Member of the Board Issuer: Optomed OyjLEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATIONReference number: 7437009IVYWGEE4S7B77_20191209094512_7____________________________________________ Transaction date:

Optomed Oyj - Managers' Transactions

Optomed Plc - Managers' Transactions - 9 December 2019, at 16.30 EET Optomed Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Tauriainen, ReijoPosition: Member of the Board/Deputy memberIssuer: Optomed OyjLEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATIONReference number: 7437009IVYWGEE4S7B77_20191209140450_2____________________________________________ Transaction date: 2019-12-05Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000410881Nature of the

Hexagon's Capital Markets Day 2019 will be broadcasted live

Hexagon will host its Capital Markets Day on Wednesday 11[th] of December in Cobham, UK. Ola Rollén, President and CEO at Hexagon, will together with members of Group Management hold presentations on current market trends, growth opportunities and key strategic focus areas.Those unable to attend the Capital Markets Day in person can follow the online broadcast live as well as on demand at hexagon.com. Please find the link to the webcast here .The webcast will be active at 10.00 GMT (11.00 CET) on Wednesday, 11[th] of December.

News update – The verification project is advancing

We are very excited to see that preparations for the verification project in Marocco is moving ahead at rapid pace. The grounds have been prepared for the equipment, which you can see from the enclosed pictures. A design verification container, including operational storage system and Stirling engine, will be unloaded on site today.The whole company is closely involved in the project. The storage unit has been installed in Åmål about one week ago and the container with the full system arrived this morning on site in Noor, Ouarzazate. During the last week, Azelio’s installation team on site

Andreas Öhrnberg leaves Talkpool at his own request

Talkpool today announces that Andreas Öhrnberg, Chief Financial Officer, has chosen to resign. He will continue in his current position through January 31, 2020. To ensure the continuity, Talkpool’s board of directors has approved the appointment of Erika Loretz, Senior Accountant of Talkpool AG, as interim CFO. Erika has been 8 years within Talkpool’s finance organisation and has previously worked at PwC Switzerland. “We thank Andreas for his dedicated service and for very successfully leading and developing Talkpool’s finance organization which has been an important step in preparing

Norway Royal Salmon ASA - NTS ASA becomes the largest shareholder of Norway Royal Salmon ASA

Reference is made to the stock exchange announcement published by NTS ASA ("NTS", OSE Ticker: NTS) today regarding the merger with the Frøy Group, including Gåsø Næringsutvikling's shareholding in NRS. The Frøy Group is owned by Gåsø Næringsutvikling, which in turn is owned by Helge Gåsø and his family.Helge Gåsø is a primary insider and chairman of the Board of Directors of NRS and through Gåsø Næringsutvikling AS owns a shareholding of 6 993 188 shares in NRS, corresponding to 16.05 % of the shares in the Company. The merger with NTS is contingent on a number of conditions, including

Transfer of EAB Group’s own shares

EAB Group Plc, Stock Exchange Release, 9 December 2019, 3:10 p.m. (EET) Transfer of EAB Group’s own shares On 9 December 2019, EAB Group Plc transferred a total of 1,354 own shares held by the company to a former key employee of the company without consideration. The transfer is related to the payment of deferred variable remuneration and is in accordance with the Company's remuneration scheme. The regulation requires that, to the extent that a reward scheme for so-called risk-takers may result in a variable remuneration of more than €50,000 per calendar year, at least 40% of the

Recipharm invests in its US inhalation development service

Recipharm, the contract development and manufacturing organisation (CDMO), has invested USD 450,000 into its Research Triangle Park (RTP), North Carolina, US facility to install a SprayVIEW® system that will support inhalation and nasal product development. The newly acquired system was installed alongside an environmental controlled aerosol collection chamber for inhalation testing and a metered dose inhaler (MDI) and dry powder inhaler (DPI) pilot process lab. SprayVIEW® is a primary instrument for the characterisation of aerosols or sprays emitted from MDIs, soft mist inhalers and

Svevind Solutions becomes W3 Energy – New independent asset manager for wind farms

The Svevind Solutions management team buys the company and changes the name to W3 Energy. The now Swedish-owned and independent company will focus on the operation, service and optimisation of wind farms in the Nordic region. “The high level of expertise amongst our employees is well recognised. With W3 Energy, we look forward to helping both existing and new customers to manage their investments in wind power”, says the new majority shareholder Per Olofsson.Based in northern Sweden, Svevind Solutions is a leading management service provider for wind farms in the Nordic countries. In 2019,

Saab Receives Order for Components for US Marine Corps G/ATOR Radar

Saab has received an order for components and subsystems for full rate production systems for the US Marine Corps Ground/Air Task Oriented Radar (G/ATOR), which has the US designation AN/TPS-80.The initial order value is USD 31.9 million and the contract includes options for additional systems over a five-year period. G/ATOR provides the US Marine Corps with capability for air surveillance, air defence, and ground weapon locating missions in one single ground-based radar solution. Saab received the order from Northrop Grumman Systems Corporation, who is the prime contractor for G/ATOR to

Offer shares of Herantis Pharma Plc registered with the Trade Register

Offer shares of Herantis Pharma Plc registered with the Trade Register Herantis Pharma PlcCompany release 9 December 2019 at 3:00 pm EET THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Herantis Pharma Plc ("Herantis" or the "Company") announced on 2 December 2019 that the Company's directed share issue announced on 11 November 2019 (the "Offering")

Invitation to Q1 presentation on 19 December

RNB RETAIL AND BRANDS will announce its first quarter results for the financial year 2019/20 (September 2019 – August 2020) on Thursday 19 December at 07.00 (CET).RNB RETAIL AND BRANDS invites investors, analysts and media to a presentation of the quarterly report, where CEO Magnus Håkansson and CFO Kristian Lustin comment on the report. The presentation will be held on 19 December at 10.00 (CET) and can be followed by telephone conference or audio broadcast. To participate in the teleconference please call before the opening of the conference: SE: +46 856 642 707 UK: +44 333 300

Outokumpu – Manager transaction: Kari Jordan

Outokumpu OyjStock exchange releaseManager transactionDecember 9, 2019 at 1.45 pm EETOutokumpu – Manager transaction: Kari Jordan Outokumpu has received a notification from Kari Jordan, member of the Board of Directors, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Name of the manager Kari JordanPosition in the issuer Member of the Board of DirectorsIssuer Outokumpu OyjIssuer’s LEI reference

BAKKAFROST - Refinancing of bank facilities

With reference to the release of 25 September 2019, Bakkafrost is pleased to announce that is has entered into binding agreements relating to two fully secured five-year credit facilities of in aggregate EUR 352m (the “New Facilities”).  The purpose of the New Facilities is to refinance Bakkafrost’s existing bank facilities, to partly fund the acquisition of shares in the Scottish Salmon Company and to secure a robust, flexible and long-term financing tailored to match the Group’s ambitions for organic and strategic growth. The New Facilities will comprise a EUR 95m multicurrency term

Press release: Nel receives purchase order for a 3.5 MW electrolyser from ENGIE

(Oslo, 9 December 2019) Nel Hydrogen Electrolyser AS, a subsidiary of Nel ASA (Nel, OSE:NEL) has received a purchase order, following a previously announced contract, for a 3.5 MW electrolyser from ENGIE. The electrolyser is an element of ENGIE's hydrogen solution to produce renewable hydrogen for the world's largest fuel cell electric mining haul truck for Anglo American, a global mining company, and is scheduled to be installed during 2020.   Reference is made to the OSE notification 30 August 2019, where Nel announced a contract to deliver “a 3.5 MW electrolyser to a large,

Aqilion sells shareholdings in portfolio company Glactone Pharma

AQILION AB is selling its entire stake in the portfolio company Glactone Pharma AB to Daniel Lifveredson Invest AB. The purchase price is divided into a smaller amount as initial payment at the time of takeover and an additional payment based on Glactone Pharma's future performance. Glactone Pharma AB was founded in 2012 as a project company within what was then known as Partners för Utvecklingsinvesteringar inom Life Sciences, P.U.L.S. AB, now known as AQILION AB. Glactone Pharma develops innovative new drug candidates for treatment of late-stage prostate cancer (castration-resistant

There are no items matching the current filter
There are no more items matching the current filter
Back to top